Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
ANIP Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
15.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
55.50%
ANIP Stock Analysis
ANIP
PE Ratio:
19.1
ANIP
PEG Ratio:
1.9
ANIP
Forward EPS Growth (12 month):
10.20%
ANIP
PS Ratio:
1.9
ANIP
PSG Ratio:
0.2
ANIP
Forward Revenue Growth (12 month):
11.70%
ANIP Articles
No data was found